search
Back to results

Massive Rotator Cuff Tear Reconstruction (SCR)

Primary Purpose

Rotator Cuff Tear Arthropathy

Status
Active
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Bridging Rotator Cuff Reconstruction
Superior Capsular Reconstruction
GRAFTJACKET™ allograft
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rotator Cuff Tear Arthropathy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Magnetic resonance imaging (MRI) proven diagnosis of a large or massive (>3cm), two-tendon (supraspinatus and infraspinatus) tear of the shoulder rotator cuff

Exclusion Criteria:

  • Presence of subscapular tear
  • Presence of glenohumeral osteoarthritis
  • WORC score > 70%
  • Uncontrolled diabetes
  • Pregnancy
  • Presence of local or systemic infection
  • Paralysis of the shoulder
  • Poor nutritional state
  • Contracture of the shoulder
  • Presence of cuff tear arthropathy
  • MRI proven nonvascular surgical sites
  • Cancer

Sites / Locations

  • Nova Scotia Health Authority

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Bridging Rotator Cuff Group

Superior Capsular Group

Arm Description

Bridging Rotator Cuff Reconstruction of massive rotator cuff tear using GRAFTJACKET™ allograft.

Superior Capsular Reconstruction of massive rotator cuff tear

Outcomes

Primary Outcome Measures

Maintenance of Acromiohumeral Distance
The primary objective of this study is to compare the effect between the two surgical techniques, arthroscopic SCR for a massive, chronic irreparable tear of the rotator cuff vs. BRR with an acellular human dermal allograft implant, on the maintenance of the Acromiohumeral distance. Acromiohumeral Distance is measured in mm and determine through xray.

Secondary Outcome Measures

Changes in Shoulder Strength After Surgery
Changes in Strength After Surgery will be measured in kilograms using a hand dynamometer.
Changes in Shoulder Range of Motion After Surgery
Changes in Shoulder Range of Motion After Surgery will be measured in degrees using a goniometer.
Changes in Patient Reported Outcomes using the Western Ontario Rotator Cuff Index (WORC)
The Western Ontario Rotator Cuff Index is a questionnaire use to evaluate patient reported outcomes. The questionnaire asks 21 questions are using a 100mm visual analogue type scale patients are asked to indicate how much pain they are experiencing doing different activities. The left end of the line indicates no pain, the right end of the line indicates extreme pain. The distance in mm from the left end of the line determines the amount of pain. To total distances for all 21 questions is added up then subtracted from 2100 and divided by 21 to give a percentage. A percentage of 100 indicates that no pain is being felt and low percentages indicates the patient is experiencing extreme pain.

Full Information

First Posted
January 31, 2018
Last Updated
August 28, 2023
Sponsor
Nova Scotia Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT03425500
Brief Title
Massive Rotator Cuff Tear Reconstruction
Acronym
SCR
Official Title
Bridging Reconstruction of Massive Rotator Cuff Tears by Human Dermal Allograft Augmentation Compared to Superior Capsular Reconstruction
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 1, 2018 (Actual)
Primary Completion Date
July 2025 (Anticipated)
Study Completion Date
August 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nova Scotia Health Authority

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To compare bridging reconstruction to superior capsular reconstruction using human dermal allograft augmentation for repair of massive rotator cuff tears.
Detailed Description
A total of 60 patients will be enrolled in the study. In the pre-operative period, there will be no additional time requirements for the patient, except for the informed consent process for the study. Routine radiographs including an AP and Y view of the shoulder as well as a pre-operative MRI are obtained for all patients undergoing rotator cuff surgery. The patients will complete a structured clinical examination conducted by a sports medicine fellowship trained orthopaedic consultant. The examination will consist of range of motion testing by goniometer as well as strength testing by hand dynamometer. The patient will also complete the WORC questionnaire. Surgical Technique All patients will undergo a 15-point arthroscopic shoulder examination as per the method outlined by Snyder. An arthroscopic acromioplasty will be performed if needed according to the technique described by Snyder. The bursal side of the tear will be evaluated. If the cuff can be re-approximated to its anatomic position on the greater tuberosity without excessive tension, a standard rotator cuff reconstruction will be attempted. If this is not possible the surgeon will determine that the cuff is "irreparable" and the randomization envelope will be opened. Wong et al. described the surgical procedure for patients in the "Bridging" group. The bursa will be debrided thoroughly and rotator cuff edges will be shaved down to stable tissue. Following this, an acellular human dermal patch will be rehydrated in saline solution for 15 minutes. The patch is stretched to remove the manufacturing surface irregularities. The patch is then sewn in place with braided polyester suture material. Multiple sutures, approximately 5 to 10 mm apart from one another will be used. The medial sutures are placed into the remnants of supraspinatus and infraspinatus tendons. The patch is then attached to the greater tuberosity in a double row configuration. The technique described by Burkhart et al will be followed for patients in the "SCR" group. The bursa will be debrided thoroughly and rotator cuff edges will be shaved down to stable tissue. Following this, an acellular human dermal patch will be rehydrated in saline solution for 15 minutes. The patch is stretched to remove the manufacturing surface irregularities. Measurement of defect size (coronal and sagittal) will take place, following that the glenoid and humeral footprint preparation will be performed utilizing an arthroscopic burr, arthroscopic bone anchors will be inserted on the glenoid footprint and graft is inserted with double pully technique. The graft is then tensioned to greater tuberosity using a double row configuration. Postoperative protocol The shoulder will be immobilized in a sling for one week postoperatively, and only passive forward flexion and external rotation will be allowed for eight weeks. The patient then progresses to active shoulder motion. Strengthening will begin at twelve weeks postoperatively. The patient will follow-up with the attending surgeon (IW) at 2 weeks post-operatively for a wound check. Then further follow-up appointments will be at 6 weeks, 3 months, 6 months, 12 and 24 months, as per current clinical practice. At the 3, 6, 12, and 24 month visits the patient will again undergo the structured clinical examination conducted by a sports medicine fellowship trained orthopaedic consultant who is blinded to the patients' treatment group. The patient will also complete the (WORC) questionnaire at these follow-up appointments. Radiograph will be taken also to obtain the postoperative measurements. MRI will be done to assess healing at 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rotator Cuff Tear Arthropathy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Control Trial
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Bridging Rotator Cuff Group
Arm Type
Experimental
Arm Description
Bridging Rotator Cuff Reconstruction of massive rotator cuff tear using GRAFTJACKET™ allograft.
Arm Title
Superior Capsular Group
Arm Type
Active Comparator
Arm Description
Superior Capsular Reconstruction of massive rotator cuff tear
Intervention Type
Procedure
Intervention Name(s)
Bridging Rotator Cuff Reconstruction
Intervention Description
Bridging Rotator Cuff Reconstruction of massive rotator cuff tear using a GRAFTJACKET™ allograft
Intervention Type
Procedure
Intervention Name(s)
Superior Capsular Reconstruction
Intervention Description
Superior Capsular Reconstruction of massive rotator cuff tear
Intervention Type
Device
Intervention Name(s)
GRAFTJACKET™ allograft
Other Intervention Name(s)
Acellular human dermal allograft
Intervention Description
The acellular human dermal allograft in used in the bridging rotator cuff reconstruction
Primary Outcome Measure Information:
Title
Maintenance of Acromiohumeral Distance
Description
The primary objective of this study is to compare the effect between the two surgical techniques, arthroscopic SCR for a massive, chronic irreparable tear of the rotator cuff vs. BRR with an acellular human dermal allograft implant, on the maintenance of the Acromiohumeral distance. Acromiohumeral Distance is measured in mm and determine through xray.
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Changes in Shoulder Strength After Surgery
Description
Changes in Strength After Surgery will be measured in kilograms using a hand dynamometer.
Time Frame
24 months
Title
Changes in Shoulder Range of Motion After Surgery
Description
Changes in Shoulder Range of Motion After Surgery will be measured in degrees using a goniometer.
Time Frame
24 months
Title
Changes in Patient Reported Outcomes using the Western Ontario Rotator Cuff Index (WORC)
Description
The Western Ontario Rotator Cuff Index is a questionnaire use to evaluate patient reported outcomes. The questionnaire asks 21 questions are using a 100mm visual analogue type scale patients are asked to indicate how much pain they are experiencing doing different activities. The left end of the line indicates no pain, the right end of the line indicates extreme pain. The distance in mm from the left end of the line determines the amount of pain. To total distances for all 21 questions is added up then subtracted from 2100 and divided by 21 to give a percentage. A percentage of 100 indicates that no pain is being felt and low percentages indicates the patient is experiencing extreme pain.
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Magnetic resonance imaging (MRI) proven diagnosis of a large or massive (>3cm), two-tendon (supraspinatus and infraspinatus) tear of the shoulder rotator cuff Exclusion Criteria: Presence of subscapular tear Presence of glenohumeral osteoarthritis WORC score > 70% Uncontrolled diabetes Pregnancy Presence of local or systemic infection Paralysis of the shoulder Poor nutritional state Contracture of the shoulder Presence of cuff tear arthropathy MRI proven nonvascular surgical sites Cancer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ivan H Wong, MD
Organizational Affiliation
Nova Scotia Health Authority
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nova Scotia Health Authority
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2E1
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Massive Rotator Cuff Tear Reconstruction

We'll reach out to this number within 24 hrs